Discounted Cash Flow
Idexx Laboratories Inc. /de
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $1.8b | $222.0m | $269.8m | 12.5% | $2.47 |
| 2017 | $2.0b (10.9%) | $263.1m (18.5%) | $298.9m (10.8%) | 13.4% (6.9%) | $3.00 (21.5%) |
| 2018 | $2.2b (12.4%) | $377.0m (43.3%) | $284.3m (-4.9%) | 17.0% (27.5%) | $4.34 (44.7%) |
| 2019 | $2.4b (8.8%) | $427.7m (13.4%) | $304.2m (7.0%) | 17.8% (4.3%) | $4.97 (14.5%) |
| 2020 | $2.7b (12.5%) | $581.8m (36.0%) | $541.1m (77.9%) | 21.5% (21.0%) | $6.82 (37.2%) |
| 2021 | $3.2b (18.8%) | $744.8m (28.0%) | $636.0m (17.5%) | 23.2% (7.8%) | $8.74 (28.2%) |
| 2022 | $3.4b (4.7%) | $679.1m (-8.8%) | $394.1m (-38.0%) | 20.2% (-12.9%) | $8.12 (-7.1%) |
| 2023 | $3.7b (8.7%) | $845.0m (24.4%) | $772.9m (96.1%) | 23.1% (14.5%) | $10.17 (25.2%) |
| 2024 | $3.9b (6.5%) | $887.9m (5.1%) | $808.1m (4.6%) | 22.8% (-1.3%) | $10.77 (5.9%) |
| 2025 | $4.3b (10.4%) | $1.1b (19.3%) | $1.1b (30.8%) | 24.6% (8.1%) | $13.17 (22.3%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.